David Sidransky insider trades

Open-market stock purchases and sales by David Sidransky, Director at Champions Oncology, Inc, from SEC Form 4 filings since Feb 22, 2010.

Recent trades

DateStockTradeValue
Nov 5, 2025CSBR Champions Oncology, IncBought (not open market)$144K

Companies traded

  • CSBR Champions Oncology, Inc: other filings, last Nov 5, 2025
  • ORGS Orgenesis Inc: 4 buys, last Dec 20, 2023
  • AYLA Old Ayala, Inc: 8 buys, last Jan 19, 2023
  • ADXS Ayala Pharmaceuticals, Inc: 2 sales, last Jan 19, 2023
  • IMNP Immune Pharmaceuticals Inc: 5 buys, last Jan 8, 2015
  • KVA/KVB KV Pharmaceutical Co /de/: other filings, last Sep 16, 2013
  • EPCTD Immune Pharmaceuticals Inc: other filings, last Aug 25, 2013
  • ACEL Tamir Biotechnology, Inc: other filings, last Jul 23, 2012
  • KVA KV Pharmaceutical Co /de/: other filings, last May 14, 2012

Get free alerts when David Sidransky files a new trade →